CommercialCoverageMedium impact
06.02.47f, Noninvasive Prenatal Screening for Fetal Aneuploidies Using Cell-Free Fetal DNA (Independence Administrators)
Independence Blue Cross·OB-GYN, Family Medicine·Medical Policy
Effective date
Jan 1, 2025
We identified it
Jun 19, 2026
Summary
Independence Administrators updated their medical policy for noninvasive prenatal screening using cell-free fetal DNA for fetal aneuploidies. This policy affects coverage and billing for prenatal genetic testing services.
Action Required
By February 14, 2025: Billing team should review the complete policy document at the provided URL to understand coverage criteria and documentation requirements for noninvasive prenatal screening claims. Update billing procedures and staff training for prenatal genetic testing services according to the new guidelines.